ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Speedway Motorsports Inc
19.78
0.0000
成交量:
- -
成交額:
- -
市值:
8.08億
市盈率:
21.28
高:
19.78
開:
19.78
低:
19.78
收:
19.78
資料載入中...
總覽
公司
新聞
公告
諾誠健華第二代泛TRK抑制劑ICP-723完成首例青少年患者給藥
美通社
·
2022-10-31
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TRK/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRK\",,,,,undefined,":{"symbol":"TRK","market":"US","secType":"STK","nameCN":"Speedway Motorsports Inc","latestPrice":19.78,"timestamp":1569009600000,"preClose":19.78,"halted":0,"volume":0,"delay":0,"floatShares":11243173,"shares":40853902,"eps":0.929399,"marketStatus":"未開盤","change":0,"latestTime":"09-20 16:00:00 EDT","open":19.78,"high":19.78,"low":19.78,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.929399,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1748419200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":793515600000,"exchange":"NYSE","adjPreClose":19.78,"dividendRate":0.030334,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRK\",,,,,undefined,":{"symbol":"TRK","floatShares":11243173,"roa":"2.83%","roe":"4.03%","lyrEps":0.988731,"shares":40853902,"dividePrice":0.6,"high":19.78,"amplitude":0,"preClose":19.78,"low":19.78,"week52Low":13.47,"pbRate":"0.85","week52High":19.9,"institutionHeld":0.2191,"latestPrice":19.78,"eps":0.929399,"divideRate":0.030334,"volume":0,"delay":0,"ttmEps":0.929399,"open":19.78,"prevYearClose":19.78},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRK\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2279765208","title":"諾誠健華第二代泛TRK抑制劑ICP-723完成首例青少年患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2279765208","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2279765208?lang=zh_tw&edition=fundamental","pubTime":"2022-10-31 11:23","pubTimestamp":1667186580,"startTime":"0","endTime":"0","summary":"北京2022年10月31日 /美通社/ -- 生物医药高科技公司诺诚健华今天宣布,公司自主研发的第二代泛TRK小分子抑制剂ICP-723在中山大学肿瘤防治中心儿童肿瘤科完成首例青少年患者给药,这也是ICP-723在成人患者中显示良好安全性和有效性后,首次在青少年患者中开展临床研究。诺诚健华也已经在美国进行ICP-723的临床研究,目前在第一个剂量组尚未观察到剂量限制性毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/3919319_ZH19319_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["ICP","TRK","BK1574","09969","BK0239","BK1161","688428"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-08-14","symbol":"TRK","amount":0.15,"name":"Speedway Motorsports Inc","payableDate":"2019-08-15","currency":"USD","type":"dividend","dateTimestamp":1565755200000},{"market":"US","date":"2019-07-31","symbol":"TRK","fiscalQuarterEnding":"2019/06","expectedEps":0.47,"name":null,"time":"盤前","type":"earning","dateTimestamp":1564545600000,"reportTimeType":"pre","actualEps":0.75},{"market":"US","date":"2019-05-14","symbol":"TRK","amount":0.15,"name":"Speedway Motorsports Inc","payableDate":"2019-05-15","currency":"USD","type":"dividend","dateTimestamp":1557806400000},{"market":"US","date":"2019-05-01","symbol":"TRK","fiscalQuarterEnding":"2019/03","expectedEps":-0.07,"name":null,"time":"盤前","type":"earning","dateTimestamp":1556683200000,"reportTimeType":"pre","actualEps":0.22},{"market":"US","date":"2019-03-13","symbol":"TRK","fiscalQuarterEnding":"2018/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1552449600000,"reportTimeType":"pre","actualEps":-0.27}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRK\",market:\"US\",,,undefined,":[{"executeDate":"2017-02-27","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-05-11","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-08-11","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2017-11-09","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"},{"executeDate":"2018-02-28","recordDate":null,"paymentDate":null,"value":0.15,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRK\",market:\"US\",delay:false,,,undefined,":{}}}